Success Stories: From NIW to EB1A: Dual Approval for Postdoctoral Associate in Molecular Medicine Research
Client’s Testimonial:
“I had a great experience working with Chen immigration attorneys. Their service was excellent at every step. Their response to my queries was very quick and helpful. Very thankful to them for my EB1 approval.”
On February 10th, 2025, we received another EB1A (Alien of Extraordinary Ability) approval for a Postdoctoral Associate in the Field of Molecular Medicine (Approval Notice).
General Field: Molecular Medicine
Position at the Time of Case Filing: Postdoctoral Associate
Country of Origin: India
State of Residence at the Time of Filing: California
Approval Notice Date: February 10th, 2025
Processing Time: 10 months, 12 days (Premium Processing Requested)
Case Summary:
We are pleased to share the success story of an EB1A (Alien of Extraordinary Ability) approval granted to a molecular medicine researcher whose work focuses on developing innovative approaches to the treatment and management of osteoarthritis. This client had previously secured EB-2 NIW approval with the support of the North America Immigration Law Group (NAILG) and has now successfully obtained EB-1A classification based on her extraordinary scientific contributions.
The client is especially recognized for her groundbreaking research on polyphenols and their impact on osteoarthritis, with additional expertise in inflammation, plant-derived compounds, and immunopathology. Her studies have produced new insights into how bioactive compounds like imperatorin and butein can reduce inflammation and improve joint health, research that addresses one of the most widespread chronic conditions affecting aging populations globally.
Her research has not only broadened scientific understanding but has also influenced the direction of therapeutic innovation. She has published 12 peer-reviewed scientific articles, which have collectively been cited 745 times by researchers in at least 56 countries. These achievements place her in the top 1% of most highly cited authors publishing on immunopathology topics over the past 8 years.
Professional Recognition and Influence:
To further demonstrate her influence in the field, the client has conducted at least 52 peer reviews for scientific journals and serves on the editorial board of a respected publication, recognitions reserved for trusted experts with deep subject matter expertise.
Her work has been supported by prestigious funding bodies, including:
- The National Center for Complementary and Integrative Health (NCCIH)
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- The National Institutes of Health (NIH)
In addition to her osteoarthritis research, she has also contributed to developing improved immunoassays for detecting antibodies to HBV surface antigens in patient samples, showcasing her versatility and translational impact in biomedical science.
A compelling expert testimonial submitted with the petition summarized the importance of her contributions:
“Her widely disseminated research is exceptional and harbors tangible implications in enhancing osteoarthritis management and improving the well-being of countless individuals, an area indispensable for societal health and longevity.”
Final Result:
This EB1A petition highlights both the client’s internationally recognized expertise and the national and global relevance of her research. NAILG was proud to support her through this process, having previously assisted her with a successful NIW petition. We are honored to play a continued role in her journey and look forward to her future contributions to science and public health.